Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Not Excluding Drug Discount Agreement. According To § 130a Paragraph. 8 Sgb V Through An Openhouse Model For The Active Ingredient Flecainide (atccode According To Who 2026-04-08
Germany The Subject Of This Publication Is The Conclusion Of Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For Pharmaceuticals Containing The Active Ingredient Tocilizumab (atc Code According To Who: L04ac07). The Contract Will Be Concluded W 2026-04-08
Germany Non-excl. Medicinal Discount Agreement According To § 130a Abs. 8 Sgb V By Means Of An Open-house Model To The Active Substance Leuprorelin (atccode By Who 2026-04-09
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph. 8 Sgb V On Medicinal Products With The Active Ingredient Bimatoprost (atccode 2026-04-09
Bulgaria "delivery Of Orthopedic Implants And Osteosynthesis Required For The Activity Of The Orthopedics And Traumatology Clinic At The University Hospital" Prof. Dr Stoyan Kirkovich "ad. 2026-04-09
India The Tender Involves The Supply Of Various Items For The North Eastern Railway, Focusing On Materials And Equipment Necessary For Railway Operations. This Includes Components For Signaling, Electrical Systems, And Other Essential Railway Infrastructure. Va 2026-04-09
Sweden Rfi Endoscopy Rigid Consumption Uro/prokto/recto/tem 2026-04-10
Spain Pursuant To Article 99 Of Law 9/2017, Of November 9, On Public Sector Contracts. (hereinafter Lcsp), It Is Necessary To Contract The Renewal Service For The Maintenance Of The Avid Editing Systems Available To The Faculty Of Information Sciences Of The Co 2026-04-10
Germany Medicines With The Active Ingredient Teriparatide (atc: H05aa02) 2026-04-11
Germany Medicines With The Active Ingredients Bempedoic Acid And Ezetimibe (atc: C10ba10) 2026-04-11
Whats app